Stay updated on Sotorasib in Stage IV NSCLC: First-line Clinical Trial
Sign up to get notified when there's something new on the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page.

Latest updates to the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page
- Check6 days agoChange DetectedThe page now includes a glossary toggle and color-coded change highlights (green for additions, red for deletions). The revision label was updated from v3.3.4 to v3.4.0.SummaryDifference0.8%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedNew system revision v3.3.4 appears in the history, and the previous revision v3.3.3 is removed from the list.SummaryDifference0.1%

- Check42 days agoChange DetectedA new page revision label (v3.3.3) was added, and the HHS Vulnerability Disclosure link along with the previous revision label (v3.3.2) were removed from the footer.SummaryDifference0.2%

- Check71 days agoChange DetectedRevision: v3.3.2 was added to the history list, replacing Revision: v3.2.0. This is a minor UI-label update on the study history page and does not affect core study data or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check78 days agoChange DetectedRemoved the government funding/operating status notice from the page, eliminating guidance that information may not be up to date and that submissions might not be processed during funding lapses.SummaryDifference0.5%

- Check92 days agoChange DetectedThe old and new screenshots show the same record history content with no new version data or status changes; differences are limited to layout and styling. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Sotorasib in Stage IV NSCLC: First-line Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page.